Stock Market Closing Bell 28 July 2025: Nifty Falls Below 24,700; Sensex Drops 408 pts as Global Weakness Persists
By CapitalKeeper | Closing Bell | Indian Equity | Market Moves That Matter
🔔 Weak Start to the Week: Nifty Ends Below 24,700, Sensex Drops 400 pts | 28 July 2025
Indian stock markets ended lower on 28 July 2025 with Nifty at 24,680.99 and Bank Nifty at 56,084.90. Persistent global weakness and profit booking dragged indices lower. Detailed sector analysis and technical outlook.
📊 Market Summary – 28 July 2025
| Index | Open | Close | Change |
|---|---|---|---|
| Nifty 50 | 24,782.45 | 24,680.99 | 🔻 -101.46 pts (-0.41%) |
| Bank Nifty | 56,215.10 | 56,084.90 | 🔻 -130.20 pts (-0.23%) |
| Sensex | 81,299.97 | 80,891.02 | 🔻 -408.95 pts (-0.50%) |
| Fin Nifty | 26,684.35 | 26,615.20 | 🔻 -69.15 pts (-0.26%) |
🧭 Market Recap – Global Weakness Weighs on D-Street
Indian equities opened the week on a negative note, with Nifty slipping below 24,700 and Sensex falling over 400 points. Persistent selling in IT, energy, and select banking heavyweights kept sentiment subdued, while FMCG and pharma stocks provided marginal support.
🔍 Key Market Drivers
- Global Jitters: Weak global equities amid cautious tone ahead of US Fed policy outcome on July 30.
- Profit Booking: Selling pressure continued in large caps post earnings announcements.
- Banking Underperformance: Private banks like HDFC Bank and Axis Bank dragged Bank Nifty lower.
- Defensive Buying: FMCG and pharma cushioned the fall in broader markets.
🌍 Global Market Snapshot
- US Futures: Flat to negative ahead of Fed policy meeting later this week.
- European Markets: Mildly lower as investors await Eurozone inflation data.
- Asian Markets: Mixed trend; Nikkei lower, Shanghai slightly positive on stimulus hopes.
- Commodities: Brent crude near $81.80/barrel; gold steady around $2,390/oz.
- Currency: INR ended at 83.76/USD, marginally weaker.
📈 Sectoral Performance
Losers:
- IT: Infosys, TCS continued decline amid weak global tech outlook.
- Energy: Reliance, ONGC saw profit booking ahead of results.
- Banking: Pressure in private banks dragged Bank Nifty lower.
Gainers:
- FMCG: ITC, HUL gained on defensive buying.
- Pharma: Cipla, Sun Pharma closed marginally positive.
📌 Notable Stock Highlights
- Reliance Industries: Declined ahead of Q1 results; heavy volume seen in F&O.
- HDFC Bank: Weakness continued; stock closed near intraday low.
- ITC & HUL: Showed resilience amid market weakness; provided support to Nifty.
- Cipla: Outperformed with mild gains, keeping pharma index stable.
🔎 Technical Insights
Nifty 50:
- Closed at 24,680; immediate support lies at 24,600–24,550.
- Resistance: 24,850–24,900; a close above this may trigger short-covering.
Bank Nifty:
- Closed at 56,084; key support at 55,850 and resistance near 56,400.
- Sustaining above 56,000 is crucial for near-term recovery.
Fin Nifty:
- Closed at 26,615; support at 26,550, resistance at 26,750.
- Trend remains sideways with mild downward bias.
Outlook for Next Session (29 July 2025)
- Markets likely to remain range-bound ahead of US Fed policy outcome.
- Watch 24,600 (Nifty) and 55,850 (Bank Nifty) as crucial supports; breach may intensify selling pressure.
- Defensive sectors like FMCG and pharma may continue to provide cushion.
CapitalKeeper View
The market continues to trade in a consolidation zone with global cues dominating sentiment. Traders should maintain cautious stance and prefer buy-on-dips only near strong support zones until Fed clarity emerges.
📌 For more real-time updates, trade setups, and investment insights follow us on [Telegram] and subscribe to our newsletter!
📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.By using this website, you agree to the terms of this disclaimer
